An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

608

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Tocilizumab

Tocilizumab administered according to prescribing information and normal clinical practice.

Trial Locations (119)

11108

Narbonne

11890

Carcassonne

12027

Rodez

13006

Marseille

13274

Marseille

13384

Marseille

13658

Salon-de-Provence

14033

Caen

20604

Bastia

21000

Dijon

22027

Saint-Brieuc

24019

Périgueux

25030

Besançon

27015

Évreux

28102

Druex

28630

Le Coudray

29609

Brest

30029

Nîmes

31059

Toulouse

31076

Toulouse

31077

Toulouse

32008

Auch

33075

Bordeaux

33076

Bordeaux

33491

Le Bouscat

33505

Libourne

34295

Montpellier

35203

Rennes

36019

Châteauroux

37170

Chambray-lès-Tours

37171

Chambray-lès-Tours

38434

Échirolles

39108

Dole

42277

Saint-Priest-en-Jarez

42403

Saint-Chamond

44035

Nantes

46005

Cahors

47307

Vlleneuve Sur Lot

49933

Angers

51092

Reims

51200

Épernay

54511

Vandœuvre-lès-Nancy

56017

Vannes

57126

Thionville

57804

Freyming-Merlebach

58000

Nevers

59037

Lille

59056

Roubaix

59208

Tourcoing

59300

Valenciennes

59322

Valenciennes

59462

Lomme

59723

Denain

60021

Beauvais

60321

Compiègne

62608

Berck

62806

Liévin

63003

Clermont-Ferrand

64109

Bayonne

66046

Perpignan

67098

Strasbourg

67500

Haguenau

68024

Colmar

68070

Mulhouse

69002

Lyon

69400

Gleizé

69437

Lyon

69495

Pierre-Bénite

69626

Villeurbanne

73106

Aix-les-Bains

74136

Bonneville

74370

Metz-Tessy

74500

Évian-les-Bains

75475

Paris

75571

Paris

75651

Paris

75679

Paris

75877

Paris

75960

Paris

76233

Bois-Guillaume

78303

Poissy

78600

Maisons-Laffitte

79302

Bressuire

80000

Amiens

80054

Amiens

81500

Lavaur

82017

Montauban

83041

Toulon

83120

Ste Maxime

83300

Draguignan

83608

Fréjus

84106

Orange

84902

Avignon

87042

Limoges

87100

Limoges

90016

Belfort

91024

Évry

91106

Corbeil-essones

Corbeil-Essonnes

92014

Nanterre

92104

Boulogne-Billancourt

92151

Suresnes

93009

Bobigny

93143

Bondy

93602

Aulnay-sous-Bois

94010

Créteil

94163

Saint-Mandé

94195

Villeneuve-Saint-Georges

94200

Ivry-sur-Seine

94275

Le Kremlin-Bicêtre

94366

Bry-sur-Marne

95300

Pontoise

01306

Belley

06401

Cannes

04000

Digne-les-Bains

05000

Gap

02001

Laon

03000

Moulins

06202

Nice

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01474291 - An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice | Biotech Hunter | Biotech Hunter